- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advance of spleen tyrosine kinase in diseases and drugs
Authors
Keywords
Splenic tyrosine kinase, Signaling pathway, Allergic disease, Targeted therapeutics
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 90, Issue -, Pages 107168
Publisher
Elsevier BV
Online
2020-11-30
DOI
10.1016/j.intimp.2020.107168
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of the deubiquitinase USP10 induces degradation of SYK
- (2020) Jing Yang et al. BRITISH JOURNAL OF CANCER
- Effects of the multi‐kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia
- (2020) Ellen Weisberg et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model
- (2020) Stephen P. McAdoo et al. KIDNEY INTERNATIONAL
- Protein‐Tyrosine Kinase, Syk Accelerates Phagosome Maturation by Depolymerizing F‐Actin in Complement‐Mediated Phagocytosis
- (2020) Hiroyuki Tabata et al. FASEB JOURNAL
- Role of spleen tyrosine kinase in liver diseases
- (2020) Dhadhang Wahyu Kurniawan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells
- (2020) David J. Lamb et al. Oncotarget
- Ranunculus bulumei Methanol Extract Exerts Anti-Inflammatory Activity by Targeting Src/Syk in NF-κB Signaling
- (2020) Yo Han Hong et al. Biomolecules
- Anti-Inflammatory Functions of Alverine via Targeting Src in the NF-κB Pathway
- (2020) Chae Young Lee et al. Biomolecules
- Structural optimization and anti-allergic activity of nucleotide aptamers target to Cε3-Cε4
- (2019) Yanlei Yang et al. BIOCHEMICAL PHARMACOLOGY
- Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice
- (2019) Dániel Csete et al. Frontiers in Immunology
- New treatments for chronic urticaria
- (2019) Pavel Kolkhir et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- IL-17A Increases Multiple Myeloma Cell Viability by Positively Regulating Syk Expression
- (2019) Shunye Wang et al. Translational Oncology
- Identifying regulatory pathways of spleen tyrosine kinase expression in human basophils
- (2019) Xia Peng et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Alveolar Bone Protection by Targeting the SH3BP2‐SYK Axis in Osteoclasts
- (2019) Mizuho Kittaka et al. JOURNAL OF BONE AND MINERAL RESEARCH
- New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines
- (2019) Yael Renert-Yuval et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- The Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin Complex
- (2019) Toufic Kassouf et al. Cancers
- Multidomain Control Over TEC Kinase Activation State Tunes the T Cell Response
- (2018) Amy H. Andreotti et al. Annual Review of Immunology
- Discovery of Novel Syk/PDGFR-α/c-Kit Inhibitors as Multi-targeting Drugs to Treat Rheumatoid Arthritis
- (2018) Xiaokang Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Syk inhibitor R406 downregulates inflammation in an in vitro model of Pseudomonas aeruginosa infection
- (2018) Alaa Alhazmi et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Furaltadone suppresses IgE-mediated allergic response through the inhibition of Lyn/Syk pathway in mast cells
- (2018) Seung Taek Nam et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia
- (2018) Sushma Bartaula-Brevik et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Autoantibodies to IgE and FcεRI and the natural variability of spleen tyrosine kinase expression in basophils
- (2018) Donald MacGlashan JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Phosphorylated immunoreceptor tyrosine-based activation motifs and integrin cytoplasmic domains activate spleen tyrosine kinase via distinct mechanisms
- (2018) Lina Antenucci et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis
- (2017) Xiaofeng Cai et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Timescale Separation of Positive and Negative Signaling Creates History-Dependent Responses to IgE Receptor Stimulation
- (2017) Brooke Harmon et al. Scientific Reports
- Reconstruction and signal propagation analysis of the Syk signaling network in breast cancer cells
- (2017) Aurélien Naldi et al. PLoS Computational Biology
- Resveratrol inhibits IgE binding and down-regulates intracellular phosphorylation of Syk following IgE aggregation on human basophils
- (2017) Sayaka Arakawa et al. ALLERGOLOGY INTERNATIONAL
- The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients
- (2016) Ana Colado et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Signal transduction and chemotaxis in mast cells
- (2016) Petr Draber et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells
- (2016) Noelia Purroy et al. Oncotarget
- CLEC-2 expression is maintained on activated platelets and on platelet microparticles
- (2014) E. Gitz et al. BLOOD
- Expression of Variant Isoforms of the Tyrosine Kinase SYK Determines the Prognosis of Hepatocellular Carcinoma
- (2014) Jian Hong et al. CANCER RESEARCH
- Differential Expression and Molecular Associations of Syk in Systemic Lupus Erythematosus T Cells
- (2014) S. Krishnan et al. JOURNAL OF IMMUNOLOGY
- The Role of the Syk/Shp-1 Kinase-Phosphatase Equilibrium in B Cell Development and Signaling
- (2014) A. Alsadeq et al. JOURNAL OF IMMUNOLOGY
- Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus
- (2014) S Iwata et al. LUPUS
- Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages
- (2012) A-Ram Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The role of the TRAF-interacting protein in proliferation and differentiation
- (2012) Christophe Chapard et al. EXPERIMENTAL DERMATOLOGY
- IgE-dependent signaling as a therapeutic target for allergies
- (2012) Donald W. MacGlashan TRENDS IN PHARMACOLOGICAL SCIENCES
- Kinase inhibitors: a new class of antirheumatic drugs
- (2012) Vasileios Kyttaris Drug Design Development and Therapy
- The protein-tyrosine kinase Syk interacts with the C-terminal region of tensin2
- (2011) Kyung D. Moon et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development
- (2011) B. A. Finney et al. BLOOD
- ER stress is implicated in mitochondrial dysfunction-induced apoptosis of pancreatic beta cells
- (2011) June Woo Lee et al. MOLECULES AND CELLS
- SYK regulates B-cell migration by phosphorylation of the F-actin interacting protein SWAP-70
- (2010) G. Pearce et al. BLOOD
- Immunotherapy for allergies and asthma: present and future
- (2010) Shyam S Mohapatra et al. CURRENT OPINION IN PHARMACOLOGY
- Mast cell signaling: The role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants
- (2010) Reuben P. Siraganian et al. FEBS LETTERS
- Syk is a dual-specificity kinase that self-regulates the signal output from the B-cell antigen receptor
- (2010) B. Heizmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autoinhibition and adapter function of Syk
- (2009) Yogesh Kulathu et al. IMMUNOLOGICAL REVIEWS
- FcɛRI-induced activation by low antigen concentrations results in nuclear signals in the absence of degranulation
- (2009) Ana Cristina G. Grodzki et al. MOLECULAR IMMUNOLOGY
- The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells
- (2009) Q Zhou et al. ONCOGENE
- An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus
- (2008) Frances Rena Bahjat et al. ARTHRITIS AND RHEUMATISM
- The kinase Syk as an adaptor controlling sustained calcium signalling and B-cell development
- (2008) Yogesh Kulathu et al. EMBO JOURNAL
- Tyr130 phosphorylation triggers Syk release from antigen receptor by long-distance conformational uncoupling
- (2008) Y. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started